TFE3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic study
Author:
Funder
Japan Society for the Promotion of Science
Kaken Pharmaceutical Co Ltd
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference40 articles.
1. Papillary renal cell carcinoma. The WHO classificaion of tumours editorial board eds. WHO classification of tumours: 5th edition. Urinary and Male Genital Tumours;Amin,2022
2. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma;Pei;Mod. Pathol.,2019
3. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion;Fukuda;Virchows Arch.,2019
4. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions;Martignoni;Mod. Pathol.,2011
5. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression;Marcon;Clin. Cancer Res.,2020
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review;Translational Cancer Research;2024-06
2. TFE3-RCC of the right kidney in an eight-year-old child;Asian Journal of Surgery;2024-06
3. Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers;Aging;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3